Methods and compounds for the treatment of genetic disease
AssigneeDesign Therapeutics, Inc.
InventorsAseem ANSARI, Pratik SHAH
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to compounds and methods which may be useful for modulating the expression of cnbp and treating diseases and conditions in which cnbp plays an active role.
Claims127
A transcription modulator molecule having a first terminus, a second terminus, and an oligomeric backbone, wherein:
- a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CCTG;
- b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CCTG;
- and
- c) the oligomeric backbone comprising a linker between the first terminus and the second terminus, with the proviso that the second terminus is not a Brd4 binding moiety.
A compound as recited in any one of the proceeding claims for use as a medicament.
A compound as recited in any one of the proceeding claims for use in the manufacture of a medicament for the prevention or treatment of a disease or condition ameliorated by the overexpression of cnbp.
A compound as recited in any one of the proceeding claims for use in the treatment of DM2.
A pharmaceutical composition comprising a compound as recited in any one of the proceeding claims together with a pharmaceutically acceptable carrier.
A method for achieving an effect in a patient comprising the administration of a therapeutically effective amount of a compound as disclosed herein, or a salt thereof, to a patient, wherein the effect is chosen from muscular disorders and cataracts, and cardiac and respiratory disorders.
Dependencies are inferred from the claim text.